Related by context. Frequent words. (Click for all words.) 67 MGCD# [001] 66 CYT# 64 CUDC 64 CRx 64 Phase Ib 63 perifosine 62 XL# [003] 62 voreloxin 61 HspE7 61 antitumor activity 61 AP# [003] 61 RDEA# 61 preclinical studies 60 ARRY 60 tolerability profile 60 tolerability 60 AEZS 60 IMGN# 59 INCB# [002] 59 taxane 59 docetaxel 59 antiviral activity 59 T DM1 58 Marqibo 58 ANA# 58 FOLOTYN 58 APD# 58 Phase 1b 58 MDV# 58 ARQ 58 AZD# 57 ADVEXIN 57 bavituximab 57 efficacy 57 preclinical 57 erlotinib 57 APF# 57 Phase 2a 57 Phase 2b clinical 57 monotherapy 57 dose escalation 57 Phase 2b trial 57 picoplatin 57 Locteron 57 hematological malignancies 57 NKTR 57 REOLYSIN 57 REOLYSIN R 57 ofatumumab 56 hematologic malignancies 56 Phase 2a clinical 56 carfilzomib 56 dose escalation study 56 immunogenicity 56 bortezomib 56 satraplatin 56 LymphoStat B 56 sorafenib 56 dosing regimens 56 carboplatin 56 Phase IIa trial 56 ERBITUX 56 elesclomol 55 5 fluorouracil 55 ACTEMRA 55 investigational drug 55 investigational compound 55 Phase 2b study 55 tivozanib 55 Phase 2b 55 IDX# 55 Phase IIb clinical 55 PROVENGE 55 oncology indications 55 pemetrexed 55 solid tumors 55 Phase III clinical 54 pharmacokinetic profile 54 orally administered 54 Genasense 54 humanized monoclonal antibody 54 pharmacokinetics 54 ispinesib 54 Nexavar 54 Phase IIb 54 daclizumab 54 HEPLISAV 54 Phase III 54 gemcitabine 54 CK # 54 Defibrotide 54 PRX # 54 Phase IIa clinical 54 Paclitaxel 54 sunitinib 54 FTY# 54 gefitinib 54 rituximab 54 Tovaxin 54 RG# [001] 54 Preclinical studies